REVOLUTIONIZING FERTILITY & REPRODUCTIVE HEALTH

  • 17.5% of the adult population – roughly 1 in 6 worldwide – experience infertility, showing the urgent need to increase access to affordable, high-quality fertility care for those in need.

    — WORLD HEALTH ORGANIZATION

  • Infertility is increasing — birth rates are dropping.

    — WORLD HEALTH ORGANIZATION

  • Since 1972, there has been a 50% drop in sperm counts.

    — WORLD HEALTH ORGANIZATION

  • Up to 50% of “normal” sperm are misshapen which decreases motility.

    — WORLD HEALTH ORGANIZATION

  • There are no new technologies to increase fertility rates for couples.

    — WORLD HEALTH ORGANIZATION

Our Solution:
Introducing AF

We’ve extracted and synthesized a marine compound, supercharging human sperm motility by over 700% on contact.

AF Fact Sheet

Is a small compound
Is Easily Synthesized
Highly Water Soluble
Stable for months at room temperature
Not harmful to the female reproductive tract
Does not damage the sperm DNA
Does not alter the sperm's ability to penetrate the egg (acrosome reaction)
Hyperactives human sperm 700% on contact

AF will revolutionize fertility treatment

  • Simple and straightforward: An easy-to-use pre-intercourse foam for women

  • Safe and natural: A marine-derived biocompound that gently works with the female reproductive system

  • Easily synthesized, highly water soluble, and stable for months

Driven by our commitment to inclusive women's health, we're launching AF as the number one fertility enhancer available as an affordable over-the-counter solution of the highest quality.

CURRENT STATUS

Our Patent for AF, its Derivatives, and Utility in vertebrate reproduction has been recorded and will be issued early 2026.

Market Advantage

  • There are no FDA approved products currently on the market that can increase sperm motility.

  • ALL infertility strategies are currently aimed at women (hormonally).

  • The fertility industry is set to reach $41B by 2026.

  • >2% (73,000) of all live births in the US (3.4M) used some form of Assisted Reproduction Techniques (ART).

Be a part of the exciting future of fertility care

The global fertility market is poised for substantial growth, driven by demand for advanced treatment options. Our novel compound positions us at the heart of this expansion, with a solution that addresses unmet needs in a thriving, multi-billion-dollar industry.

Join us on this promising journey that will transform the landscape of infertility treatment. We are seeking development partners to help us bring this novel treatment to market.